Cargando…

Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes

BACKGROUND: Guidelines recommend that clinicians identify individuals at high cardiometabolic risk and support weight loss in those with overweight or obesity. However, we lack individual level data quantifying the benefits of weight change for individuals to guide consultations in primary care. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Elizabeth, Jebb, Susan A, Oke, Jason, Nickless, Alecia, Ahern, Amy, Boyland, Emma, Caterson, Ian D, Halford, Jason, Hauner, Hans, Aveyard, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959667/
https://www.ncbi.nlm.nih.gov/pubmed/33685923
http://dx.doi.org/10.3399/bjgp20X714113
_version_ 1783664998919176192
author Morris, Elizabeth
Jebb, Susan A
Oke, Jason
Nickless, Alecia
Ahern, Amy
Boyland, Emma
Caterson, Ian D
Halford, Jason
Hauner, Hans
Aveyard, Paul
author_facet Morris, Elizabeth
Jebb, Susan A
Oke, Jason
Nickless, Alecia
Ahern, Amy
Boyland, Emma
Caterson, Ian D
Halford, Jason
Hauner, Hans
Aveyard, Paul
author_sort Morris, Elizabeth
collection PubMed
description BACKGROUND: Guidelines recommend that clinicians identify individuals at high cardiometabolic risk and support weight loss in those with overweight or obesity. However, we lack individual level data quantifying the benefits of weight change for individuals to guide consultations in primary care. AIM: To examine how weight change affects cardiometabolic risk factors, and to facilitate shared decision making between patients and clinicians regarding weight loss. DESIGN AND SETTING: Observational analysis using data from two trials of referral of individuals with overweight or obesity in primary care to community weight-loss groups. METHOD: Linear mixed effects regression modelling examining the association between weight change and change in systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting glucose, glycated haemoglobin (HbA1c), and lipid profile across multiple timepoints (baseline to 24 months). Subgroup analyses examined changes in individuals with hypertension, diabetes, and hyperlipidaemia. RESULTS: In total, 2041 participants had a mean (standard deviation) age of 50 (SD 13.5) years, mean baseline weight of 90.6 (14.8) kg and mean body mass index (BMI) of 32.7 (SD 4.1) kg/m(2). Mean (SD) weight change was −4.3 (SD 6.0) kg. All outcome measures showed statistically significant improvements. Each 1 kg weight loss was associated with 0.4 mmHg reduction in SBP and 0.3 mmHg reduction in DBP, or 0.5 mmHg and 0.4 mmHg/kg respectively in people with hypertension. Each 1 kg weight loss was associated with 0.2 mmol/mol reduction in HbA1c, or 0.6 mmol/mol in people with diabetes. Effects on plasma lipids were negligible. CONCLUSION: Weight loss achieved through referral to community weight-loss programmes, which are commonly accessible in primary care, can lead to clinically relevant reductions in BP and glucose regulation, especially in those at highest risk.
format Online
Article
Text
id pubmed-7959667
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-79596672021-03-17 Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes Morris, Elizabeth Jebb, Susan A Oke, Jason Nickless, Alecia Ahern, Amy Boyland, Emma Caterson, Ian D Halford, Jason Hauner, Hans Aveyard, Paul Br J Gen Pract Research BACKGROUND: Guidelines recommend that clinicians identify individuals at high cardiometabolic risk and support weight loss in those with overweight or obesity. However, we lack individual level data quantifying the benefits of weight change for individuals to guide consultations in primary care. AIM: To examine how weight change affects cardiometabolic risk factors, and to facilitate shared decision making between patients and clinicians regarding weight loss. DESIGN AND SETTING: Observational analysis using data from two trials of referral of individuals with overweight or obesity in primary care to community weight-loss groups. METHOD: Linear mixed effects regression modelling examining the association between weight change and change in systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting glucose, glycated haemoglobin (HbA1c), and lipid profile across multiple timepoints (baseline to 24 months). Subgroup analyses examined changes in individuals with hypertension, diabetes, and hyperlipidaemia. RESULTS: In total, 2041 participants had a mean (standard deviation) age of 50 (SD 13.5) years, mean baseline weight of 90.6 (14.8) kg and mean body mass index (BMI) of 32.7 (SD 4.1) kg/m(2). Mean (SD) weight change was −4.3 (SD 6.0) kg. All outcome measures showed statistically significant improvements. Each 1 kg weight loss was associated with 0.4 mmHg reduction in SBP and 0.3 mmHg reduction in DBP, or 0.5 mmHg and 0.4 mmHg/kg respectively in people with hypertension. Each 1 kg weight loss was associated with 0.2 mmol/mol reduction in HbA1c, or 0.6 mmol/mol in people with diabetes. Effects on plasma lipids were negligible. CONCLUSION: Weight loss achieved through referral to community weight-loss programmes, which are commonly accessible in primary care, can lead to clinically relevant reductions in BP and glucose regulation, especially in those at highest risk. Royal College of General Practitioners 2021-03-09 /pmc/articles/PMC7959667/ /pubmed/33685923 http://dx.doi.org/10.3399/bjgp20X714113 Text en © The Authors http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/).
spellingShingle Research
Morris, Elizabeth
Jebb, Susan A
Oke, Jason
Nickless, Alecia
Ahern, Amy
Boyland, Emma
Caterson, Ian D
Halford, Jason
Hauner, Hans
Aveyard, Paul
Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
title Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
title_full Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
title_fullStr Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
title_full_unstemmed Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
title_short Effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
title_sort effect of weight loss on cardiometabolic risk: observational analysis of two randomised controlled trials of community weight-loss programmes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959667/
https://www.ncbi.nlm.nih.gov/pubmed/33685923
http://dx.doi.org/10.3399/bjgp20X714113
work_keys_str_mv AT morriselizabeth effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT jebbsusana effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT okejason effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT nicklessalecia effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT ahernamy effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT boylandemma effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT catersoniand effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT halfordjason effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT haunerhans effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes
AT aveyardpaul effectofweightlossoncardiometabolicriskobservationalanalysisoftworandomisedcontrolledtrialsofcommunityweightlossprogrammes